Retrieve available abstracts of 88 articles: HTML format
Single Articles
June 2025
LI Y, Liu X, Li W, Hou L, et al Diagnostic and Prognostic Significance of Peripheral Blood RASSF1A, P16, and
PTGER4 Gene Methylation in Adult Acute Leukemia.
Eur J Haematol. 2025 Jun 3. doi: 10.1111/ejh.14442. PubMedAbstract available
KRUSZEWSKI M, Schmoor C, Berg T, Rehman UU, et al Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid
by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I Study.
Eur J Haematol. 2025 Jun 3. doi: 10.1111/ejh.14426. PubMedAbstract available
TADMOR T, Melamed G, Alapi H, Rokach L, et al CLLAF SCORE-A New Risk Score for Predicting Atrial Fibrillation in
Treatment-Naive CLL Patients Initiating First- and Second-Generation BTK
Inhibitor Therapy.
Eur J Haematol. 2025;114:1011-1019. PubMedAbstract available
May 2025
ALNUGHMUSH A, Alyamany R, Remberger M, Pasic I, et al Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With
Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation
Cyclophosphamide Based GVHD Prophylaxis.
Eur J Haematol. 2025 May 28. doi: 10.1111/ejh.14438. PubMedAbstract available
KOCKEROLS C, Valk PJM, Hogenbirk P, Geelen I, et al Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical
Cohort of CML Patients.
Eur J Haematol. 2025;114:900-907. PubMedAbstract available
April 2025
FRISCH A, Ganzel C, Ofran Y, Krayem B, et al Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With
Allo Transplant in Second Remission.
Eur J Haematol. 2025;114:641-649. PubMedAbstract available
March 2025
LOHRBERG M, Heber M, Ries L, Markus K, et al Dual Targeting of Pim and PI3 Kinases in Mature T-Cell Lymphoma.
Eur J Haematol. 2025 Mar 31. doi: 10.1111/ejh.14420. PubMedAbstract available
CHEN D, Cantu M, Siddon A, Weinberg OK, et al TP53-Mutated Acute Myeloid Leukemia and Blast Phase Myeloproliferative Neoplasm:
Distinct Mutation Leads to Poorer Prognosis.
Eur J Haematol. 2025 Mar 28. doi: 10.1111/ejh.14421. PubMedAbstract available
POONSOMBUDLERT K, Yodsuwan R, Mott S, Crawford K, et al Effect of NPM1 Mutation Subtype and Co-Mutation Patterns on the Outcomes of Acute
Myeloid Leukemia.
Eur J Haematol. 2025 Mar 19. doi: 10.1111/ejh.14415. PubMedAbstract available
ZHENG R, Gagan JR, Botten GA, Koduru P, et al Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With
Immunophenotypic Lineage Predominance: Impact on Diagnosis and Treatment.
Eur J Haematol. 2025 Mar 18. doi: 10.1111/ejh.14414. PubMedAbstract available
CHUNG C, Doan D Targeting the Immune Microenvironment in Chronic Lymphocytic Leukemia: An
Evolving Therapeutic Strategy.
Eur J Haematol. 2025 Mar 11. doi: 10.1111/ejh.14408. PubMedAbstract available
NAGAFUJI K, Ito Y, Miyamoto T, Eto T, et al Clinical Impact of Continuous Dasatinib Administration on the Prognosis of
Patients With BCR::ABL1 Acute Lymphoblastic Leukemia: Result of the Prospective
MRD2014 Study Conducted by Fukuoka Blood and Marrow Transplantation Group
(FBMTG).
Eur J Haematol. 2025 Mar 7. doi: 10.1111/ejh.14407. PubMedAbstract available
BRUZZESE A, Martino EA, Labanca C, Carida G, et al Therapeutic Strategies for Relapsed or Refractory B-Cell Acute Lymphoblastic
Leukemia in Adult Patients: Optimizing the Use of Monoclonal Antibodies.
Eur J Haematol. 2025 Mar 6. doi: 10.1111/ejh.14405. PubMedAbstract available
GHIMIRE B, Zimmer M, Donthireddy V TP53-Mutated Acute Myeloid Leukemia: Review of Treatment and Challenges.
Eur J Haematol. 2025 Mar 4. doi: 10.1111/ejh.14404. PubMedAbstract available
February 2025
VEYHE SR, Hansen MH, Cedile O, Moller MB, et al A Case-Driven Multi-Omics Analysis for Longitudinal Ibrutinib Response Evaluation
of Patients With Chronic Lymphocytic Leukemia.
Eur J Haematol. 2025 Feb 23. doi: 10.1111/ejh.14397. PubMedAbstract available
CASTELLET H, Ramil G, Carricondo M, Onate G, et al Measurable Residual Disease in UBTF-TD Adult Acute Myeloid Leukemia.
Eur J Haematol. 2025 Feb 23. doi: 10.1111/ejh.14402. PubMed
ROBAK T, Robak M, Majchrzak A, Krawczynska A, et al Atypical Hairy Cell Leukemia-The Current Status and Future Directions.
Eur J Haematol. 2025 Feb 10. doi: 10.1111/ejh.14388. PubMedAbstract available
BENOIT TM, Bachofner A, Wolfensberger N, Zaugg-Berger Y, et al Inferior Overall Survival After Haploidentical Donor Lymphocyte Infusions in
Relapsed Myeloid Neoplasms.
Eur J Haematol. 2025;114:315-324. PubMedAbstract available
BRESSER H, Schmoor C, Grishina O, Pfeifer D, et al Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans
Retinoic Acid or Valproic Acid to Decitabine.
Eur J Haematol. 2025;114:231-237. PubMedAbstract available
January 2025
HYPPOLITO JE, Arcuri LJ, Vicente A, Farnese V, et al Central Nervous System Involvement in Chronic Lymphocytic Leukemia: A
Case-Series.
Eur J Haematol. 2025 Jan 31. doi: 10.1111/ejh.14389. PubMed
YANG MM, Singh R, Haugen M, Duff A, et al Adherence to 6-Mercaptopurine (6-MP) and Habit Strength in Pediatric Acute
Lymphoblastic Leukemia (ALL).
Eur J Haematol. 2025 Jan 20. doi: 10.1111/ejh.14386. PubMedAbstract available
ZALAPA-SOTO J, Rios-Olais FA, Chacon-Rangel LC, Mora-Canas A, et al Hyper-CVAD and Modified CALGB-10403 Regimens in Adult Patients With
Philadelphia-Negative Acute Lymphoblastic Leukemia: A Comparative Study.
Eur J Haematol. 2025 Jan 7. doi: 10.1111/ejh.14381. PubMedAbstract available
BRUZZESE A, Martino EA, Labanca C, Mendicino F, et al Advances and Challenges in Quizartinib-Based FLT3 Inhibition for Acute Myeloid
Leukemia: Mechanisms of Resistance and Prospective Combination Therapies.
Eur J Haematol. 2025 Jan 6. doi: 10.1111/ejh.14383. PubMedAbstract available
BERTON G, Hospital MA, Garciaz S, Rouzaud C, et al Outcomes of Elderly Patients Admitted to the Intensive Care Unit for Newly
Diagnosed Acute Myeloid Leukemia.
Eur J Haematol. 2025 Jan 6. doi: 10.1111/ejh.14366. PubMedAbstract available
JENSEN ABH, Andersen HRP, Jensen ST, Jensen CF, et al Musculoskeletal Symptoms and Misdiagnoses in Children With Acute Myeloid
Leukaemia: A Nationwide Cohort Study.
Eur J Haematol. 2025;114:57-69. PubMedAbstract available
December 2024
PUCKRIN R, Owen C, Peters A Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic
Lymphocytic Leukemia.
Eur J Haematol. 2024 Dec 27. doi: 10.1111/ejh.14376. PubMedAbstract available
TANG MW, Van der Tuin D, Aydin M, Heijmans J, et al Comparison of HiDAC Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid
Leukemia and High-Risk Myelodysplastic Syndrome.
Eur J Haematol. 2024 Dec 26. doi: 10.1111/ejh.14370. PubMedAbstract available
ROWE M, Babushok D, Carroll M, Carulli A, et al Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax
Based Regimen.
Eur J Haematol. 2024 Dec 26. doi: 10.1111/ejh.14371. PubMedAbstract available
November 2024
MORT JF, Brighton D, DiBenedetto S, Wells L, et al Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk
Acute Myeloid Leukemia.
Eur J Haematol. 2024 Nov 27. doi: 10.1111/ejh.14354. PubMedAbstract available
YALNIZ FF, Johnson A, Alnimer Y, Chahine Z, et al Unveiling the Genetic and Clinical Differences of Acute Myeloid Leukemia (AML) in
Obese Patients.
Eur J Haematol. 2024 Nov 13. doi: 10.1111/ejh.14338. PubMedAbstract available
CHEN EY, Dahlen T, Stenke L, Bjorkholm M, et al Loss in Overall and Quality-Adjusted Life Expectancy for Patients With
Chronic-Phase Chronic Myeloid Leukemia.
Eur J Haematol. 2024 Nov 6. doi: 10.1111/ejh.14328. PubMedAbstract available
SMITH E, Atenafu EG, Bankar A, Chan S, et al Evolution from an antecedent chronic myeloid malignancy does not impact survival
outcomes in NPM1-mutated AML.
Eur J Haematol. 2024;113:716-726. PubMedAbstract available
October 2024
SHACHAM-ABULAFIA A, Volcheck Y, Ellis M, Shapira S, et al Asciminib in Advanced-Line Treatment of Chronic Myeloid Leukemia.
Eur J Haematol. 2024 Oct 21. doi: 10.1111/ejh.14330. PubMedAbstract available
BRUZZESE A, Martino EA, Labanca C, Mendicino F, et al Therapy-Related Acute Promyelocytic Leukemia: Case Series and Current Insights.
Eur J Haematol. 2024 Oct 13. doi: 10.1111/ejh.14327. PubMedAbstract available
September 2024
MURRAY GF, Bouligny IM, Ho T, Gor J, et al Clonal Evolution in 207 Cases of Refractory or Relapsed Acute Myeloid Leukemia.
Eur J Haematol. 2024 Sep 24. doi: 10.1111/ejh.14308. PubMedAbstract available
STEINER N, Massoud R, Richter J, Perekhrestenko T, et al Comparable Results Between 8 and 12 Gray TBI in Combination With Fludarabine and
Post-Transplant Cyclophosphamide in MRD-Negative but Not in MRD-Positive Acute
Lymphoblastic Leukemia Patients Transplanted in First Complete Remission.
Eur J Haematol. 2024 Sep 19. doi: 10.1111/ejh.14305. PubMedAbstract available
BUCELLI C, Capodanno I, Miggiano MC, Cavazzini F, et al Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly
Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study.
Eur J Haematol. 2024 Sep 12. doi: 10.1111/ejh.14299. PubMedAbstract available
WILLE K, Dumke M, Wilsdorf N, Sadjadian P, et al Venetoclax Combined With FLAG-IDA in Refractory or Relapsed Acute Myeloid
Leukemia.
Eur J Haematol. 2024 Sep 9. doi: 10.1111/ejh.14302. PubMedAbstract available
ISHIKAWA C, Mori N A New Strategy for Adult T-Cell Leukemia Treatment Targeting Glycogen Synthase
Kinase-3beta.
Eur J Haematol. 2024 Sep 6. doi: 10.1111/ejh.14300. PubMedAbstract available
LIN S, Liao N, Li X, Yang L, et al Prognosis of pediatric BCP-ALL with IKZF1 deletions and impact of intensive
chemotherapy: Results of SCCLG-2016 study.
Eur J Haematol. 2024;113:357-370. PubMedAbstract available
August 2024
SOUA A, Gilhodes J, Iat A, Hicheri Y, et al Venetoclax-based non-intensive induction followed by allogenic stem-cell
transplantation in elderly acute myeloid leukemia patients with adverse
cytogenetics.
Eur J Haematol. 2024 Aug 11. doi: 10.1111/ejh.14290. PubMedAbstract available
July 2024
RANTI J, Pudas H, Ranta M, Tuominen S, et al Treatment and clinical outcomes of patients with acute myeloid leukemia in
Finland 2010-2020: A retrospective analysis of electronic health records.
Eur J Haematol. 2024 Jul 29. doi: 10.1111/ejh.14272. PubMedAbstract available
ACKER F, Chromik J, Tiedjen E, Wolf S, et al Real-world effectiveness of first-line azacitidine or decitabine with or without
venetoclax in acute myeloid leukemia patients unfit for intensive therapy.
Eur J Haematol. 2024 Jul 18. doi: 10.1111/ejh.14278. PubMedAbstract available
KOCKEROLS C, Valk PJM, Janssen JJWM, Hogenbirk P, et al Prediction of sustained remission after tyrosine kinase inhibitor discontinuation
with BCR::ABL1 digital PCR in chronic myeloid leukemia patients.
Eur J Haematol. 2024 Jul 12. doi: 10.1111/ejh.14271. PubMedAbstract available
LINES M, Kemper RM, Wallace J, Alexander T, et al Use of allopurinol to manage skewed 6-mercaptopurine metabolism in pediatric
maintenance acute lymphoblastic leukemia treatment.
Eur J Haematol. 2024 Jul 11. doi: 10.1111/ejh.14273. PubMedAbstract available
GUEUNING C, Lazaro E, Dupuy H, Leonard C, et al Characteristics of large granular lymphocyte leukemia associated with variable
common immunodeficiency disorders: A study of 12 cases.
Eur J Haematol. 2024 Jul 10. doi: 10.1111/ejh.14265. PubMedAbstract available
June 2024
SKIPPER MT, Birkebaek N, Jensen RB, Rank CU, et al Pancreas-related persisting sequelae in ALL survivors with a history of
asparaginase-associated pancreatitis: A part of the ALL-STAR study.
Eur J Haematol. 2024;112:944-956. PubMedAbstract available
GERHARDT A, Dorfel S, Schulz H, Schlag R, et al Outcomes with ibrutinib in patients with chronic lymphocytic leukaemia: Results
from the German multicentre REALITY study.
Eur J Haematol. 2024;112:927-937. PubMedAbstract available
KUTSCH N, Godel P, Voltin CA, Hallek M, et al Long-term remission in a patient with relapsed Richter's transformation treated
with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell
transplantation.
Eur J Haematol. 2024;112:984-987. PubMedAbstract available
May 2024
TAGHILOO S, Asgarian-Omran H Cross-talk between leukemic and immune cells at the tumor microenvironment in
chronic lymphocytic leukemia: An update review.
Eur J Haematol. 2024 May 2. doi: 10.1111/ejh.14224. PubMedAbstract available
KUTSCH N, Giza A, Robrecht S, Stumpf J, et al Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients
with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study
Group (GCLLSG) registry.
Eur J Haematol. 2024 May 1. doi: 10.1111/ejh.14220. PubMedAbstract available
April 2024
AFTANDILIAN C, Bito XR, Berman D, Zhang A, et al Plasma microbial cell-free DNA following chimeric antigen receptor T cell therapy
in pediatric patients with relapsed/refractory leukemia.
Eur J Haematol. 2024 Apr 24. doi: 10.1111/ejh.14216. PubMedAbstract available
MARRA JD, Galli E, Giammarco S, Metafuni E, et al CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia
relapsing after hematopoietic stem cell transplantation.
Eur J Haematol. 2024 Apr 21. doi: 10.1111/ejh.14217. PubMedAbstract available
MIKLOS E, Oliver TP, Adam K, Eva K, et al Fix low dose venetoclax-azacitidine treatment of unfit acute myeloid leukemia
patients.
Eur J Haematol. 2024 Apr 21. doi: 10.1111/ejh.14213. PubMedAbstract available
GRONLUND JK, Veigaard C, Juhl-Christensen C, Skou AS, et al Droplet digital PCR for sensitive relapse detection in acute myeloid leukaemia
patients transplanted by reduced intensity conditioning.
Eur J Haematol. 2024;112:601-610. PubMedAbstract available
DELANOTE V, Callens R, Vogelaers D, Deeren D, et al Screening for multidrug-resistant organisms in high-risk hospitalized patients
with hematologic diseases.
Eur J Haematol. 2024;112:627-632. PubMedAbstract available
PETIT C, Saillard C, Mohty B, Hicheri Y, et al Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction
failure or first relapsed acute myeloid leukaemia patients.
Eur J Haematol. 2024;112:530-537. PubMedAbstract available
ISHIKAWA C, Mori N Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult
T-cell leukemia.
Eur J Haematol. 2024 Apr 1. doi: 10.1111/ejh.14209. PubMedAbstract available
March 2024
POONSOMBUDLERT K, Mott S, Miller B, Dhakal P, et al Transplant versus no transplant in myelodysplastic syndrome and acute myeloid
leukemia with TP53 mutation; a referral center experience.
Eur J Haematol. 2024 Mar 21. doi: 10.1111/ejh.14199. PubMedAbstract available
ZHANG X, Zhang K, Zhang J, Chang W, et al DNMTs-mediated SOCS3 methylation promotes the occurrence and development of AML.
Eur J Haematol. 2024;112:439-449. PubMedAbstract available
GARCIA-POUTON N, Ortiz-Maldonado V, Peyrony O, Chumbita M, et al Infection epidemiology in relation to different therapy phases in patients with
haematological malignancies receiving CAR T-cell therapy.
Eur J Haematol. 2024;112:371-378. PubMedAbstract available
February 2024
GAO J, Santana-Santos L, Fu L, Alvey E, et al Clinical implications of additional chromosomal abnormalities in adult acute
myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
Eur J Haematol. 2024 Feb 22. doi: 10.1111/ejh.14192. PubMedAbstract available
SUN Y, Zhu G, Zhong H Minimal residual disease monitoring in acute myeloid leukemia: Focus on MFC-MRD
and treatment guidance for elderly patients.
Eur J Haematol. 2024 Feb 11. doi: 10.1111/ejh.14187. PubMedAbstract available
MELLINGHOFF SC, Robrecht S, Sprute R, Mayer L, et al Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia.
Eur J Haematol. 2024 Feb 4. doi: 10.1111/ejh.14170. PubMedAbstract available
INFANTE JB, Esteves GV, Raposo J, de Lacerda JF, et al Disseminated intravascular coagulation score evolution in 48 h predicts early
death in acute promyelocytic leukemia patients.
Eur J Haematol. 2024 Feb 2. doi: 10.1111/ejh.14177. PubMedAbstract available
SEVOYAN A, Mekinian A, Chermat F, Ades L, et al MDS/CMML from resource-limited region: Characteristics and comparison to tertiary
reference European center.
Eur J Haematol. 2024;112:296-300. PubMedAbstract available
January 2024
WIESEN MHJ, Stemler J, Fietz C, Joisten C, et al Quantification of midostaurin in plasma and serum by stable isotope dilution
liquid chromatography-tandem mass spectrometry: Application to a cohort of
patients with acute myeloid leukemia.
Eur J Haematol. 2024 Jan 31. doi: 10.1111/ejh.14178. PubMedAbstract available
PODGORICA M, Drivet E, Viken JK, Richman A, et al Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic
leukemia identifies pathogenic variants and gene fusions, and predicts subtypes
for in depth molecular diagnosis.
Eur J Haematol. 2024 Jan 8. doi: 10.1111/ejh.14164. PubMedAbstract available
MOYEN TB, Tomaz V, Campregher PV Feasibility, accuracy, and usability analysis of MapAML, a first-in-class app for
integrated diagnosis in acute myeloid leukemia.
Eur J Haematol. 2024 Jan 3. doi: 10.1111/ejh.14158. PubMedAbstract available
GUPTA S, Kohorst M, Alkhateeb HB Determinants of outcomes and advances in CD19-directed chimeric antigen receptor
therapy for B-cell acute lymphoblastic leukemia.
Eur J Haematol. 2024;112:51-63. PubMedAbstract available
WANG XY, Bian MR, Lin GQ, Yu L, et al Tandem bispecific CD123/CLL-1 CAR-T cells exhibit specific cytolytic effector
functions against human acute myeloid leukaemia.
Eur J Haematol. 2024;112:83-93. PubMedAbstract available
JI Q, Wu X, Zhang Y, Zeng L, et al Adverse events and efficacy of second-round CAR-T cell therapy in relapsed
pediatric B-ALL.
Eur J Haematol. 2024;112:75-82. PubMedAbstract available
KHAN AN, Asija S, Pendhari J, Purwar R, et al CAR-T cell therapy in hematological malignancies: Where are we now and where are
we heading for?
Eur J Haematol. 2024;112:6-18. PubMedAbstract available
December 2023
TAMEFUSA K, Ochi M, Ishida H, Shiwaku T, et al Delayed diagnostic interval and survival outcomes in pediatric leukemia: A
single-center, retrospective study.
Eur J Haematol. 2023 Dec 28. doi: 10.1111/ejh.14162. PubMedAbstract available
MORI T, Osumi T, Kada A, Ohki K, et al Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell
non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial.
Eur J Haematol. 2023 Dec 19. doi: 10.1111/ejh.14148. PubMedAbstract available
NEUMANN MA, Nieper P, Simon F, Shimabukuro-Vornhagen A, et al A diagnostic challenge-First case of chronic lymphatic leukemia-associated
necrotizing sweet syndrome.
Eur J Haematol. 2023 Dec 17. doi: 10.1111/ejh.14153. PubMedAbstract available
COSTA A, Carmosino I, Scalzulli E, Minotti C, et al Early death risk score in acute promyelocytic leukemia: A retrospective analysis
from a monocentric cohort.
Eur J Haematol. 2023 Dec 14. doi: 10.1111/ejh.14155. PubMed
LAGANA A, Pepe S, Scalzulli E, Carmosino I, et al One-month qRT-PCR BCR::ABL1 transcript threshold to predict early recurrence in
chronic phase CML patients attempting first treatment free remission.
Eur J Haematol. 2023;111:970-972. PubMed
November 2023
NEVEJAN L, Labarque V, Boeckx N Chronic myeloid leukemia (CML) in children and adolescents-Clinicopathological
findings.
Eur J Haematol. 2023 Nov 20. doi: 10.1111/ejh.14137. PubMedAbstract available
LEE BJ, Griffin SP, Doh J, Chan A, et al HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly
diagnosed B-cell acute lymphoblastic leukemia.
Eur J Haematol. 2023 Nov 6. doi: 10.1111/ejh.14125. PubMedAbstract available
October 2023
SEGHATOL-ESLAMI VC, Cook EW 3rd, Sharafeldin N, Wolfson J, et al Adaptive functioning and academic achievement in pediatric survivors of acute
lymphoblastic leukemia: Associations with executive functioning, socioeconomic
status, and academic support.
Eur J Haematol. 2023 Oct 5. doi: 10.1111/ejh.14112. PubMedAbstract available
KRISTENSEN DT, Brondum RF, Orskov AD, Marcher CW, et al Venetoclax-based therapy for relapsed or refractory acute myeloid leukaemia
following intensive induction chemotherapy.
Eur J Haematol. 2023;111:573-582. PubMedAbstract available
MIYAJIMA T, Onozawa M, Yoshida S, Miyashita N, et al Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD
positive AML.
Eur J Haematol. 2023;111:620-627. PubMedAbstract available
BREINHOLT MF, Schejbel L, Gang AO, Nielsen TH, et al Next generation sequencing in routine diagnostics of mature non-Hodgkin's B-cell
lymphomas.
Eur J Haematol. 2023;111:583-591. PubMedAbstract available
September 2023
AGRAWAL V, Murphy L, Pourhassan H, Pullarkat V, et al Optimizing CAR-T cell therapy in adults with B-cell acute lymphoblastic leukemia.
Eur J Haematol. 2023 Sep 29. doi: 10.1111/ejh.14109. PubMedAbstract available
KOCKEROLS C, Valk PJM, Blijlevens NMA, Cornelissen JJ, et al BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide
chronic myeloid leukemia patient population.
Eur J Haematol. 2023 Sep 20. doi: 10.1111/ejh.14107. PubMedAbstract available
CHATTERJEE G, Dhende P, Raj S, Shetty V, et al 15-color highly sensitive flow cytometry assay for post anti-CD19 targeted
therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment
in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challenges.
Eur J Haematol. 2023 Sep 14. doi: 10.1111/ejh.14102. PubMedAbstract available
ZARLING LC, Stevenson PA, Soma LA, Martino CH, et al Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute
lymphoblastic leukemia.
Eur J Haematol. 2023 Sep 5. doi: 10.1111/ejh.14089. PubMedAbstract available